The Recruitment of Systemic-to-Pulmonary Arterial Collaterals in Chronic and Severe Precapillary Pulmonary Hypertension as an Adaptive or Misguided Mechanism

BACKGROUND: The clinical impact of systemic-to-pulmonary arterial collaterals (SPCs) across pulmonary hypertension (PH) groups remains unclear. The authors evaluated the prevalence, clinical correlates, and prognostic relevance of SPCs in a comprehensive PH cohort. METHODS: The authors retrospectively analyzed 434 adult PH patients diagnosed per European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines. Baseline risk was evaluated using multiparametric risk scores. All patients underwent diagnostic heart catheterization and angiography, with SPC recruitment semi-quantitatively graded from 0 (none) to 3 (severe, high grade: 2-3). RESULTS: Mean age was 51.9 ± 18.2 years (61.1% female; groups 1, 2, 3, and 4 comprised 51.6%, 3.4%, 10.1%, and 33.2%, respectively). High-grade SPCs were significantly more prevalent in group 4 (58.3%) compared to groups 1 (30.4%), 2 (20.0%), and 3 (6.8%) (P <.001). Higher SPC grade significantly correlated with PH severity across clinical, echocardiographic, hemodynamic, and risk score measures (P <.001). Although higher SPC grades were linked to clinical worsening requiring parenteral prostacyclins (P = .027), they were not associated with overall 5-year survival, regardless of pulmonary vascular resistance severity or non-CTEPH etiology (P = .920). Only the Registry to Evaluate Early and Long-Term PAH Disease Management 2.0 score independently predicted mortality (hazard ratio [HR] = 1.19, P <.001, 95% CI: 1.13-1.26). CONCLUSION: Systemic-to-pulmonary arterial collaterals are recruited across all PH etiology groups beyond group 4. While SPC recruitment serves as a marker of advanced pulmonary vascular involvement and elevated risk status, it does not act as an independent driver of long-term mortality.

Authors

Institutions

Publication Details

Journal
The Anatolian Journal of Cardiology
Published
2026-11-17
DOI
https://doi.org/10.14744/anatoljcardiol.2026.6587
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Recruitment of Systemic-to-Pulmonary Arterial Collaterals in Chronic and Severe Precapillary Pulmonary Hypertension as an Adaptive or Misguided Mechanism

Zübeyde Bayram, Barkın Kültürsay, Seda Tanyeri, Aykun Hakgör et al.
1 links
The Anatolian Journal of Cardiology
Pulmonary Hypertension Research and Treatments
article

The Recruitment of Systemic-to-Pulmonary Arterial Collaterals in Chronic and Severe Precapillary Pulmonary Hypertension as an Adaptive or Misguided Mechanism

Zübeyde Bayram, Barkın Kültürsay, Seda Tanyeri, Aykun Hakgör, Çağlar Emre Çağlıyan, Berhan Keskin, Ali Karagöz, İbrahi̇m Hali̇l Tanboğa, Dicle Sırma, Cıhangır Kaymaz, Tahsin Güneysu, Hacer Ceren Tokgöz, Çağdaş Buluş, Nihal Özdemir, Metehan Kibar, Müge Ildızlı Demirbas
article en

Abstract

BACKGROUND: The clinical impact of systemic-to-pulmonary arterial collaterals (SPCs) across pulmonary hypertension (PH) groups remains unclear. The authors evaluated the prevalence, clinical correlates, and prognostic relevance of SPCs in a comprehensive PH cohort. METHODS: The authors retrospectively analyzed 434 adult PH patients diagnosed per European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines. Baseline risk was evaluated using multiparametric risk scores. All patients underwent diagnostic heart catheterization and angiography, with SPC recruitment semi-quantitatively graded from 0 (none) to 3 (severe, high grade: 2-3). RESULTS: Mean age was 51.9 ± 18.2 years (61.1% female; groups 1, 2, 3, and 4 comprised 51.6%, 3.4%, 10.1%, and 33.2%, respectively). High-grade SPCs were significantly more prevalent in group 4 (58.3%) compared to groups 1 (30.4%), 2 (20.0%), and 3 (6.8%) (P <.001). Higher SPC grade significantly correlated with PH severity across clinical, echocardiographic, hemodynamic, and risk score measures (P <.001). Although higher SPC grades were linked to clinical worsening requiring parenteral prostacyclins (P = .027), they were not associated with overall 5-year survival, regardless of pulmonary vascular resistance severity or non-CTEPH etiology (P = .920). Only the Registry to Evaluate Early and Long-Term PAH Disease Management 2.0 score independently predicted mortality (hazard ratio [HR] = 1.19, P <.001, 95% CI: 1.13-1.26). CONCLUSION: Systemic-to-pulmonary arterial collaterals are recruited across all PH etiology groups beyond group 4. While SPC recruitment serves as a marker of advanced pulmonary vascular involvement and elevated risk status, it does not act as an independent driver of long-term mortality.

The Anatolian Journal of Cardiology
Başkent University (TR), Istanbul Medipol University (TR), Başkent University Hospital (TR), Kartal Koşuyolu High Specialization Training and Research Hospital (TR), Atlas Üniversitesi (TR), Cukurova University (TR)
Good health and well-being
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon